Georges Gemayel - 03 Jan 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
Executive Chair of the Board, Director
Signature
/s/ Brian Piekos, attorney-in-fact
Issuer symbol
IRON
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 15:04:30 UTC
Previous filing
16 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Award $0 +793,274 $0.000000 793,274 03 Jan 2022 Common Stock 793,274 $3.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the Option Shares shall become exercisable on August 5, 2022 and the remaining 50% of the Option Shares shall become exercisable on August 5, 2023.